About Blaze Bioscience
Blaze Bioscience is a company based in Seattle (United States) founded in 2010. It operates as a HealthTech. Blaze Bioscience has raised $123.7 million across 12 funding rounds. The company has 27 employees as of December 31, 2022. Blaze Bioscience offers products and services including Tumor Paint, CANVAS Imaging System, and Tozuleristide. Blaze Bioscience operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Seattle, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Blaze Bioscience, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$123.7 M (USD)
in 12 rounds
-
Latest Funding Round
$8.06 M (USD), Series D
Feb 15, 2024
-
Investors
-
Employee Count
27
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Blaze Bioscience
Blaze Bioscience offers a comprehensive portfolio of products and services, including Tumor Paint, CANVAS Imaging System, and Tozuleristide. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Technology is used for cancer detection and removal.
System is designed to enhance cancer treatment imaging.
Drug is developed for cancer surgery imaging applications.
Unlock access to complete
Unlock access to complete
Funding Insights of Blaze Bioscience
Blaze Bioscience has successfully raised a total of $123.7M across 12 strategic funding rounds. The most recent funding activity was a Series D round of $8.06 million completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 12
- Last Round Series D — $8.1M
-
First Round
First Round
(17 Oct 2011)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Series D - Blaze Bioscience | Valuation |
investors |
|
| Oct, 2022 | Amount | Series D - Blaze Bioscience | Valuation |
investors |
|
| Oct, 2021 | Amount | Series D - Blaze Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Blaze Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Blaze Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Blaze Bioscience Comparisons
Competitors of Blaze Bioscience
Blaze Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Blaze Bioscience
Frequently Asked Questions about Blaze Bioscience
When was Blaze Bioscience founded?
Blaze Bioscience was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Where is Blaze Bioscience located?
Blaze Bioscience is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Is Blaze Bioscience a funded company?
Blaze Bioscience is a funded company, having raised a total of $123.7M across 12 funding rounds to date. The company's 1st funding round was a Series D of $15M, raised on Oct 17, 2011.
How many employees does Blaze Bioscience have?
As of Dec 31, 2022, the latest employee count at Blaze Bioscience is 27.
What does Blaze Bioscience do?
Blaze Bioscience, Inc. is dedicated to enhancing the lives of cancer patients through innovative biotechnology solutions. The company is engaged in the development of Tumor Paint technology, including the CANVAS imaging system, to improve the detection, removal, and treatment of cancers. Solutions are aimed at making cancer management more sensitive, reliable, and accessible. The focus is placed on applications in cancer surgery, high-risk surveillance, and screening through collaborations and partnerships.
Who are the top competitors of Blaze Bioscience?
Blaze Bioscience's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
What products or services does Blaze Bioscience offer?
Blaze Bioscience offers Tumor Paint, CANVAS Imaging System, and Tozuleristide.